General Provisions - The company aims to protect the legal rights of shareholders and creditors, and to regulate its organization and behavior according to relevant laws [3][4] - The company is established as a foreign-invested joint-stock company under Chinese law, with a registered capital of RMB 6,637,984,837 [4][5] Business Objectives and Scope - The company's business objective is to introduce advanced technology and management methods for the production and testing of blood products, aiming to enhance production capacity and quality to international standards [5][6] - The company is engaged in the production and sale of blood products, vaccines, diagnostic reagents, and testing services, with the ability to adjust its business scope as needed [6] Shares - The company's shares are issued in the form of stocks, with a total of 6,637,984,837 shares, each with a par value of RMB 1 [7] - The issuance of shares follows principles of openness, fairness, and justice, ensuring equal rights for all shareholders of the same class [7][8] Shareholder and Shareholder Meeting - The company recognizes the rights of shareholders to receive dividends, participate in meetings, supervise operations, and transfer shares [14][16] - Shareholders holding more than 10% of shares can request the convening of a temporary shareholder meeting [25][26] Board of Directors - The board of directors is responsible for the overall management of the company, including the election and remuneration of directors and supervisors [18][19] - The board must report to the shareholders on its activities and financial performance annually [69] Financial Accounting and Auditing - The company must establish a financial accounting system and conduct internal audits, with external auditors appointed by the shareholders [8] Amendments to the Articles - The articles of association can be amended by a resolution passed at a shareholder meeting [20][21]